Recent Reports


2011-11-14: Biotechnology and Pharmaceuticals Report
5 leading Analysts; and top management from 4 Sector Firms examine this industry.
Order this Report
More Information

2011-10-31: Health Care IT Report
4 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-10-17: Medical Research, Diagnostic Substances & Life Science Tools Report
4 leading Analysts; and top management from 3 Sector Firms examine this industry.
Order this Report
More Information

2011-10-03: Medical Real Estate Report
3 leading Analysts; and top management from 3 Sector Firms examine industry.
Order this Report
More Information

2011-07-11: Medical Devices Report
5 leading Analysts; and top management from 12 Sector Firms examine this industry.
Order this Report
More Information

2011-06-27: Health Care IT Report
6 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

2011-06-13: Medical Research, Diagnostic Substances & Life Science Tools Report
5 leading Analysts; and top management from 3 Sector Firm examine this industry.
Order this Report
More Information

2011-04-04: Biotechnology and Pharmaceuticals Report
3 leading Analysts; and top management from 5 Sector Firms examine this industry.
Order this Report
More Information

2011-01-24: Medical Devices Report
3 leading Analysts; and top management from 9 Sector Firms examine this industry.
Order this Report
More Information

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.


Analyst Interview Excerpt
OUTLOOK FOR MEDICAL DEVICES – JOHN M. PUTNAM – DAWSON JAMES SECURITIES, INC.


Full article published: 09/29/2008


For Subscribers

Get this article online now!

Order just this article
TWST: Where do you concentrate your attention in the medical devices space?
Mr. Putnam: We concentrate our attention on small to mid-cap stocks and companies. We leave the large ones to some of our competitors to follow, although I've followed Medtronic (MDT) for more than 30 years now. So even though we concentrate on small to mid-caps, we still have to know what the big guys are doing because they are the big gorillas. But our main focus is on companies under 1 billion in market cap.

TWST: From a business perspective, do you approach the space broadly or are you focused on certain segments within medical devices?
Mr. Putnam: No, we have some concentration, but we do take a broad approach as well. The concentrations that are prevalent are orthopedics, particularly spine, minimally invasive spine surgery companies and companies that develop biologicals for bone growth stimulation. We have a focus on diagnostic companies as well.

 

Tickers included in this excerpt: CBMX, NUVA, VITA, OSUR, HAE

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.